401 related articles for article (PubMed ID: 3016961)
41. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
42. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?
Strada SJ; Thompson WJ
Adv Cyclic Nucleotide Res; 1978; 9():265-83. PubMed ID: 208379
[No Abstract] [Full Text] [Related]
43. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
Kireeva NN; Bobruskin ID; Severin SE
Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
[TBL] [Abstract][Full Text] [Related]
44. Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms.
Keravis TM; Wells JN; Hardman JG
Biochim Biophys Acta; 1980; 613(1):116-29. PubMed ID: 6246952
[TBL] [Abstract][Full Text] [Related]
45. Cyclic nucleotide phosphodiesterase in developing rat testis. Identification of somatic and germ-cell forms.
Geremia R; Rossi P; Pezzotti R; Conti M
Mol Cell Endocrinol; 1982 Sep; 28(1):37-53. PubMed ID: 6290290
[TBL] [Abstract][Full Text] [Related]
46. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
Donnelly TE; Barron B
Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
[TBL] [Abstract][Full Text] [Related]
47. Calcium-independent activation of calcium ion dependent cyclic nucleotide phosphodiesterase by synthetic compounds: quinazolinesulfonamide derivatives.
Tanaka T; Yamada E; Sone T; Hidaka H
Biochemistry; 1983 Mar; 22(5):1030-4. PubMed ID: 6301535
[TBL] [Abstract][Full Text] [Related]
48. Effect of trifluoperazine on cyclic nucleotide phosphodiesterase activity in crude homogenates of bovine adrenal medulla.
Crimaldi AA; Kuo IC; Coffee CJ
Ann N Y Acad Sci; 1980; 356():367-8. PubMed ID: 6263155
[No Abstract] [Full Text] [Related]
49. Regulation of multiple forms of cyclic nucleotide phosphodiesterase from bovine hypothalamus: new factors modulating enzyme activity.
Galoyan AA; Gurvitz BYa
Neurochem Res; 1985 Nov; 10(11):1467-81. PubMed ID: 3003614
[TBL] [Abstract][Full Text] [Related]
50. Cyclic 3':5'-nucleotide phosphodiesterase determined in various human tissues by DEAE-cellulose chromatography.
Hidaka H; Yamaki T; Ochiai Y; Asano T; Yamabe H
Biochim Biophys Acta; 1977 Oct; 484(2):398-407. PubMed ID: 199262
[TBL] [Abstract][Full Text] [Related]
51. Biochemical characterization of postsynaptically localized cyclic nucleotide phosphodiesterase.
Ariano MA; Appleman MM
Brain Res; 1979 Nov; 177(2):301-9. PubMed ID: 227534
[TBL] [Abstract][Full Text] [Related]
52. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
Hait WN; Weiss B
Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
[No Abstract] [Full Text] [Related]
53. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
Azhar S; Menon KM
Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
[TBL] [Abstract][Full Text] [Related]
54. Mechanism of activation of cyclic nucleotide phosphodiesterase: requirement of the binding of four Ca2+ to calmodulin for activation.
Huang CY; Chau V; Chock PB; Wang JH; Sharma RK
Proc Natl Acad Sci U S A; 1981 Feb; 78(2):871-4. PubMed ID: 6262778
[TBL] [Abstract][Full Text] [Related]
55. Phosphodiesterase activities for cyclic nucleotides in nerve endings from the bovine posterior pituitary gland.
Vale MR; Baker RV; Hope DB
J Neurochem; 1984 Feb; 42(2):377-83. PubMed ID: 6319599
[TBL] [Abstract][Full Text] [Related]
56. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
Azhaeva EV; Severin ES
Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
[TBL] [Abstract][Full Text] [Related]
57. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates.
Grewal J; Karuppiah N; Mutus B
Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449
[TBL] [Abstract][Full Text] [Related]
58. Characterization of Neurospora crassa cyclic AMP phosphodiesterase activated by calmodulin.
Téllez-Iñón MT; Ulloa RM; Glikin GC; Torres HN
Biochem J; 1985 Dec; 232(2):425-30. PubMed ID: 3004404
[TBL] [Abstract][Full Text] [Related]
59. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
60. Calmodulin sensitive phosphodiesterase of porcine cerebral cortex: kinetic behavior, calmodulin activation, and stability.
Keravis TM; Duemler BH; Wells JN
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):365-72. PubMed ID: 3040819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
